Artificial Intelligence | Machine Learning VeriSIM Life | Building AI Enabled Biosimulation Models


Enterprise, Healthcare, Biotechnology, Machine Learning, Drug Development, Clinical Trials & Development San Francisco, CA, United States

VeriSIM Life

Artificial Intelligence | Machine Learning


VeriSIM Life | Building AI Enabled Biosimulation Models

VeriSIM Life

Healthcare, Biotechnology, Machine Learning, Drug Development, Clinical Trials & Development


San Francisco, CA, United States

VeriSIM Life is building AI enabled biosimulation models. VeriSIM will tackle one of the biggest obstacles of drug development: animal testing for drug development. Animal testing is slow, ethically questionable, and doesn't act as much of a filter: 92% of all drug candidates that pass this preclinical testing never make it to market.

VeriSIM's solution is to create disease-specific biosimulation models, which allow researchers at pharma companies to model in software how a drug will interact in animals. This will allow researchers to test 1000x more potential candidates in the same unit of time, ensuring that drugs that do make it to (human) clinical trials are far more likely to work, and therefore saving millions in annual costs.

 

B2B

1 to 25

Series A

$21.7 M

Scaling Up

2017

 
 

Pharmaceuticals and Medical Products
Healthcare
Biotechnology

Improve Efficiency & Accuracy
Increase Human Life Expectancy

Increase Efficiency

 
 

Risk (AML, Fraud)
Service

Yes

Active

 
 

   Machine Learning


Drug Discovery

Drug Discovery


N/A

 

   Software


N/A


Machine Learning Algorithm

Machine Learning Algorithm

 
 

View All

Technical Sales Representative

San Francisco, California

Senior Scientist - Modeling & Simulation

San Francisco, California

Associate Director

San Francisco, California

 

AI/ML Professionals

Want to work at VeriSIM Life?

We can introduce you to the right person at VeriSIM Life

Talk to our Talent Team

 

7

1

$15M

Company was founded 2017 and it took almost 5 years (Jan 2022) to raise first external round

 
 

Date

Round

$ Raised

Investors

01/06/2022

Series A

$15M

Morpheus Ventures, Debiopharm Innovation Fund, Colorcon Ventures, OCA Ventures, Intel Capital, Serra Ventures, Susa Ventures

Date : 01/06/2022

Round: Series A

$ Raised: $15M

Investors: Morpheus Ventures, Debiopharm Innovation Fund, Colorcon Ventures, OCA Ventures, Intel Capital, Serra Ventures, Susa Ventures

 

Investors

Interested in researching VeriSIM Life?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about VeriSIM Life

Request a Demo - Deal Souring Platform

 
Jo Varshney


Jo Varshney
Founder & CEO

Kaushik Chakravarty


Kaushik Chakravarty
Head of Translational Sciences

Ted Ira


Ted Ira
Vice President, Global Sales & Strategy

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ VeriSIM Life